LB Pharmaceuticals logo
Healthcare & Life Sciences

LB Pharmaceuticals

New York, United Stateslbpharma.us

LB Pharmaceuticals is a series a startup based in United States. Status: dead.

Defunctseries-c-plus
series-c-plus
Stage
2
Investors

About LB Pharmaceuticals

LB Pharmaceuticals is a company headquartered in New York, the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

LB Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases, including schizophrenia. Its lead product candidate is LB-102, an oral small molecule.

Explore LB Pharmaceuticals's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States